Prevention of macrovascular complications in patients with type 2 diabetes mellitus: Review of cardiovascular safety and efficacy of newer diabetes medications

DOI: 10.4239/wjd.v10.i6.324

Keywords: Newer antidiabetic medications, Glucagon-like peptide-1 receptor agonist, Sodium-glucose cotransporter-2 inhibitors, Type 2 diabetes mellitus, Macrovascular complications, Cardiovascular outcome trials, Major cardiovascular events, Heart failure, Prevention of heart disease

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text